Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New contact lens study checks fit and movement for young eyes

NCT ID NCT06609018

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two types of soft contact lenses in 73 children and teenagers (ages 8 to 18) with nearsightedness. Researchers checked how well the lenses stayed centered on the eye and moved with each blink after at least three hours of wear. The goal was to see which lens performed better for everyday use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

73 people

The number who actually took part.

Started

Aug 2024

Finished

Mar 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: i. Age 8 to 18 years; at least half the population will be children or adolescents aged 8 to 15 years. ii. Have experience with soft contact lens wear and able to insert and remove soft contact lenses. iii. Parent/guardian and participant have read and understood the Participant Information Sheet. iv. Parent/guardian and participant have read, signed and dated the Informed Consent and Assent (when applicable). v. Best corrected visual acuity of at least 20/25 in each eye. vi. Have normal eyes with the exception of the need for visual correction. vii. Spectacle refraction: * Age 8 to 12: -0.75D to -4.00D spherical equivalent, with cylinder ≤ -0.75D and maximum anisometropia of \<1.00D * Age 13-18: -0.75D to -7.00D spherical equivalent, with cylinder ≤ -0.75D and maximum anisometropia of \<1.00D. viii. Be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule. Exclusion Criteria: i. Acute and subacute inflammation or infection of the anterior chamber of the eye. ii. Any eye disease, injury, or abnormality that affects the cornea, conjunctiva, or eyelids. iii. Severe insufficiency of lacrimal secretion (dry eyes). iv. Corneal hypoesthesia (reduced corneal sensitivity), if not aphakic. v. Any systemic disease that may affect the eye or be exaggerated by wearing contact lenses. vi. Allergic reactions of ocular surfaces or adnexa that may be induced or exaggerated by wearing contact lenses or use of contact lens solutions. vii. Any active corneal infection (bacterial, fungal, or viral). viii. The patient is unable to follow lens handling and wear regimen or unable to obtain assistance to do so. ix. Newly prescribed use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator. x. Monocular participants (only one eye with functional vision) or participants fit with only one lens. xi. Subjects with slit lamp findings greater than grade 1 (e.g., edema, infiltrates, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival, anterior segment inflammation) as per ISO 11980:2012, any previous history or signs of a contact lens related corneal inflammatory event (past corneal ulcers), or any other ocular abnormality that may contraindicate contact lens wear at the enrolment visit. xii. History of herpetic keratitis, ocular surgery or irregular cornea. xiii. Enrolment of the family members of the investigator, family members of the investigator's staff, or individuals living in the households of these individuals.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ocular Technology Group - International

    London, SW1E 6AU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.